Stock 4AFX CARL ZEISS MEDITEC AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Carl Zeiss Meditec AG Borsa Italiana

Equities

4AFX

DE0005313704

End-of-day quote Borsa Italiana
Other stock markets
 18:00:00 2024-06-19 EDT 		5-day change 1st Jan Change
66 EUR +0.15% Intraday chart for Carl Zeiss Meditec AG -2.29% -33.12%
06-24 RBC lowers target for Carl Zeiss Meditec to 85 euros - 'Outperform' DP
06-24 UBS lowers Carl Zeiss Meditec to 'Neutral' - target to 71 euros DP

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company benefits from high valuations in earnings multiples.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CARL ZEISS MEDITEC AG Stock Carl Zeiss Meditec AG
-33.12% 6.41B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+6.62% 216B
B
DANAHER CORPORATION Stock Danaher Corporation
+10.99% 190B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+27.18% 152B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+32.69% 113B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.71% 64.04B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+18.26% 54.34B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+1.63% 49.21B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-2.84% 39.41B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+1.98% 35.99B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. 4AFX Stock
  5. Ratings Carl Zeiss Meditec AG